
- <Centre d'Information et de documentation du CRA Rhône-Alpes
- CRA
- Informations pratiques
		- 
						Adresse
						Centre d'information et de documentation Horaires
 du CRA Rhône-Alpes
 Centre Hospitalier le Vinatier
 bât 211
 95, Bd Pinel
 69678 Bron CedexLundi au Vendredi Contact
 9h00-12h00 13h30-16h00Tél: +33(0)4 37 91 54 65 Mail
 Fax: +33(0)4 37 91 54 37
 
- 
						Adresse
						
Auteur J. Helen YOO
|  | 
Documents disponibles écrits par cet auteur (2)
 
                
             
            
                
                     
                
             
						
					
						
							 Faire une suggestion  Affiner la recherche
						
					   Faire une suggestion  Affiner la rechercheControlled Evaluation of the Effects of Hyperbaric Oxygen Therapy on the Behavior of 16 Children with Autism Spectrum Disorders / Bryan JEPSON in Journal of Autism and Developmental Disorders, 41-5 (May 2011)

Titre : Controlled Evaluation of the Effects of Hyperbaric Oxygen Therapy on the Behavior of 16 Children with Autism Spectrum Disorders Type de document : texte imprimé Auteurs : Bryan JEPSON, Auteur ; Doreen GRANPEESHEH, Auteur ; Jonathan TARBOX, Auteur ; Melissa L. OLIVE, Auteur ; Carol STOTT, Auteur ; Scott BRAUD, Auteur ; J. Helen YOO, Auteur ; Andrew WAKEFIELD, Auteur ; Michael S. ALLEN, Auteur Année de publication : 2011 Article en page(s) : p.575-588 Langues : Anglais (eng) Mots-clés : Hyperbaric oxygen therapy Autism Behavioral pharmacology Index. décimale : PER Périodiques Résumé : Hyperbaric oxygen therapy (HBOT) has been used to treat individuals with autism. However, few studies of its effectiveness have been completed. The current study examined the effects of 40 HBOT sessions at 24% oxygen at 1.3 ATA on 11 topographies of directly observed behavior. Five replications of multiple baselines were completed across a total of 16 participants with autism spectrum disorders. No consistent effects were observed across any group or within any individual participant, demonstrating that HBOT was not an effective treatment for the participants in this study. This study represents the first relatively large-scale controlled study evaluating the effects of HBOT at the level of the individual participant, on a wide array of behaviors. En ligne : http://dx.doi.org/10.1007/s10803-010-1075-y Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=121 
in Journal of Autism and Developmental Disorders > 41-5 (May 2011) . - p.575-588[article] Controlled Evaluation of the Effects of Hyperbaric Oxygen Therapy on the Behavior of 16 Children with Autism Spectrum Disorders [texte imprimé] / Bryan JEPSON, Auteur ; Doreen GRANPEESHEH, Auteur ; Jonathan TARBOX, Auteur ; Melissa L. OLIVE, Auteur ; Carol STOTT, Auteur ; Scott BRAUD, Auteur ; J. Helen YOO, Auteur ; Andrew WAKEFIELD, Auteur ; Michael S. ALLEN, Auteur . - 2011 . - p.575-588.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 41-5 (May 2011) . - p.575-588
Mots-clés : Hyperbaric oxygen therapy Autism Behavioral pharmacology Index. décimale : PER Périodiques Résumé : Hyperbaric oxygen therapy (HBOT) has been used to treat individuals with autism. However, few studies of its effectiveness have been completed. The current study examined the effects of 40 HBOT sessions at 24% oxygen at 1.3 ATA on 11 topographies of directly observed behavior. Five replications of multiple baselines were completed across a total of 16 participants with autism spectrum disorders. No consistent effects were observed across any group or within any individual participant, demonstrating that HBOT was not an effective treatment for the participants in this study. This study represents the first relatively large-scale controlled study evaluating the effects of HBOT at the level of the individual participant, on a wide array of behaviors. En ligne : http://dx.doi.org/10.1007/s10803-010-1075-y Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=121 Relevance of Donepezil in Enhancing Learning and Memory in Special Populations: A Review of the Literature / J. Helen YOO in Journal of Autism and Developmental Disorders, 37-10 (November 2007)

Titre : Relevance of Donepezil in Enhancing Learning and Memory in Special Populations: A Review of the Literature Type de document : texte imprimé Auteurs : J. Helen YOO, Auteur ; Maria G. VALDOVINOS, Auteur ; Dean C. WILLIAMS, Auteur Année de publication : 2007 Article en page(s) : p.1883-1901 Langues : Anglais (eng) Mots-clés : Autism Donepezil-(Aricept) Acetylcholine Index. décimale : PER Périodiques Résumé : This review discusses the laboratory and clinical research supporting the rationale for the efficacy of donepezil (Aricept® USA) in enhancing cognition in autism, Alzheimer disease, Down syndrome, traumatic brain injury, Attention Deficit Hyperactivity Disorder (ADHD), and schizophrenia. While preliminary animal models have shown effective, human studies exclusive of Alzheimer disease are sparse. Although attention and memory are unlikely a sole operation of the cholinergic system, evidence indicates a promising direction for further examination of this hypothesis in autism. Studies that examine changes in operationally defined behaviors and reliable and valid measure of changes in attention and memory are needed. 
En ligne : http://dx.doi.org/10.1007/s10803-006-0322-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=219 
in Journal of Autism and Developmental Disorders > 37-10 (November 2007) . - p.1883-1901[article] Relevance of Donepezil in Enhancing Learning and Memory in Special Populations: A Review of the Literature [texte imprimé] / J. Helen YOO, Auteur ; Maria G. VALDOVINOS, Auteur ; Dean C. WILLIAMS, Auteur . - 2007 . - p.1883-1901.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 37-10 (November 2007) . - p.1883-1901
Mots-clés : Autism Donepezil-(Aricept) Acetylcholine Index. décimale : PER Périodiques Résumé : This review discusses the laboratory and clinical research supporting the rationale for the efficacy of donepezil (Aricept® USA) in enhancing cognition in autism, Alzheimer disease, Down syndrome, traumatic brain injury, Attention Deficit Hyperactivity Disorder (ADHD), and schizophrenia. While preliminary animal models have shown effective, human studies exclusive of Alzheimer disease are sparse. Although attention and memory are unlikely a sole operation of the cholinergic system, evidence indicates a promising direction for further examination of this hypothesis in autism. Studies that examine changes in operationally defined behaviors and reliable and valid measure of changes in attention and memory are needed. 
En ligne : http://dx.doi.org/10.1007/s10803-006-0322-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=219 

